Andere talen Diaceutics PLC

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:13 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
96,5 ^GBX	-1,03%		-3,02%	+10,92%

02/04	Aandelen Roadside opgeschort; Adnams zoekt fondsen	AN
21/03	Diaceutics verbetert commercialiseringsplatform voor diagnosesitc, DXRX	AN

Roadside shares suspended; Adnams looks for funds	02/04
Diaceutics upgrades diagnositc commercialisation platform, DXRX	21/03
Diaceutics PLC Launches Significant Upgrade to Its DXRX Platform	21/03
Sondrel wins USD23 million contract	27/02
Diaceutics Expands Lab Network, Data Coverage in Europe	27/02
Diaceutics announces new marketing partnership with KPMG	14/02
Diaceutics maintains "momentum" for year ahead on revenue rise in 2023	30/01
Diaceutics revenue grows but loss widens, CEO Keeling to step down	26-09-23
Diaceutics Announces Executive Changes	26-09-23
Diaceutics CEO to Resign; Chief Innovation Officer Named Successor	26-09-23
Earnings Flash (DXRX.L) DIACEUTICS Posts H1 Revenue GBP9.9M	26-09-23
Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2023	26-09-23
Diaceutics PLC Announces Executive Changes, Effective 1 October 2023	21-09-23
Diaceutics launches daily alerts for DXRX platform	29-08-23
Diaceutics plc Launches Daily Alerts for Dxrx Platform	29-08-23
Diaceutics interim revenue jumps as order book grows to GBP24 million	25-07-23
Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023	25-07-23
Diaceutics shares surge on contract win with top US firm	05-06-23
AIM WINNERS & LOSERS: Tristel hails FDA approval of ULT disinfectant	05-06-23
Diaceutics Up 13% Following Three-year Enterprise Contract With Global Pharma Company	05-06-23

Geen resultaten voor deze zoekopdracht